Description

Product Description

Myristoyl tripeptide-1 is a chemically modified tripeptide designed for advanced cosmetic research. The conjugation of myristic acid to Tripeptide-1 enhances lipophilicity, facilitating peptide penetration into the stratum corneum and improving bioavailability in topical formulations. This peptide functions as a signaling molecule that interacts with epidermal keratinocytes and dermal fibroblasts, modulating pathways involved in skin conditioning, barrier integrity, and cellular repair.

Laboratory studies demonstrate that Myristoyl tripeptide-1 stimulates fibroblast proliferation and promotes the synthesis of extracellular matrix proteins, including collagen types I and III, elastin, and fibronectin. These effects contribute to improved skin firmness, elasticity, and overall texture. Its lipid modification allows for enhanced retention within the epidermal layers, providing prolonged biological activity and research reproducibility.

The peptide has been reported to influence the expression of key growth factors such as TGF-β and IGF-1, which regulate dermal matrix remodeling and epidermal renewal. By enhancing the molecular cross-talk between dermal and epidermal layers, Myristoyl tripeptide-1 supports comprehensive skin conditioning effects in laboratory settings.

In cosmetic research, this peptide is studied for its ability to improve skin hydration, reinforce the skin barrier, and mitigate the effects of environmental stressors such as UV exposure and oxidative damage. Its amphiphilic structure allows for formulation versatility, making it suitable for incorporation into serums, creams, emulsions, and other topical research matrices.

In vitro assays confirm that Myristoyl tripeptide-1 demonstrates minimal cytotoxicity and favorable biocompatibility, supporting its use in controlled cosmetic peptide research. It is frequently combined with other peptides, antioxidants, or moisturizing agents to evaluate synergistic effects on dermal conditioning, anti-aging, and skin barrier enhancement.

Product Specifications

Mechanism of Action

Myristoyl tripeptide-1 acts primarily as a skin-conditioning and signaling peptide. Its mechanism involves modulation of dermal-epidermal communication, enhancement of extracellular matrix synthesis, and support of barrier function.

1. Fibroblast Activation and Collagen Stimulation

The peptide stimulates fibroblast proliferation and enhances the expression of collagen types I and III, elastin, and fibronectin. This action strengthens dermal architecture, improves elasticity, and contributes to visible skin firmness.

2. Epidermal Barrier Enhancement

By upregulating key lipids and proteins in keratinocytes, Myristoyl tripeptide-1 reinforces the stratum corneum barrier. Enhanced barrier integrity improves water retention, skin hydration, and resilience against environmental stressors.

3. Growth Factor Modulation

Myristoyl tripeptide-1 increases TGF-β and IGF-1 expression in dermal fibroblasts. This signaling cascade promotes extracellular matrix remodeling, epidermal renewal, and cellular repair mechanisms relevant to skin conditioning research.

4. Synergistic Peptide Activity

When combined with complementary peptides, antioxidants, or moisturizing agents, Myristoyl tripeptide-1 exhibits enhanced effects on skin barrier function, hydration, and anti-aging pathways. This supports multi-component research into peptide-based formulations.

5. Enhanced Penetration via Lipid Modification

Myristic acid conjugation improves lipophilicity, allowing better diffusion through the stratum corneum and prolonged retention in epidermal layers. This feature enables reproducible experimental outcomes in topical research.

Side Effects

In controlled laboratory conditions, Myristoyl tripeptide-1 exhibits minimal cytotoxicity and low irritation potential. No adverse reactions were observed in reconstructed human epidermal models.

As with all research peptides, experimental outcomes may vary with solvent, pH, and concentration. Researchers should conduct preliminary cytotoxicity and stability testing prior to formulation studies. The peptide should be stored away from heat, light, and moisture and is intended exclusively for laboratory research use.

Keywords

Myristoyl tripeptide-1, skin conditioning peptide, barrier enhancement, hydration peptide, cosmetic peptide, peptide supplier China, OEM & bulk peptide production, high-purity cosmetic peptides, factory peptide supplier

Shipping Guarantee

All shipments are handled using validated cold-chain logistics to preserve peptide integrity. Each package is sealed in moisture-proof containers with secondary protective wrapping and continuous temperature monitoring. Products are shipped via express international couriers with full tracking and insurance coverage.

Trade Assurance

We ensure product authenticity, verified ≥99% purity, and compliance with analytical standards (HPLC, MS, and NMR). Each batch is supplied with a Certificate of Analysis (CoA). Our trade assurance policy guarantees replacement or refund for any deviation from listed specifications.

Payment Support

We provide flexible and secure global payment options to support international research transactions. Accepted payment methods include PayPal, major credit cards (Visa, MasterCard, American Express), telegraphic transfer (T/T), and cryptocurrencies (USDT, Bitcoin, Ethereum). All transactions are protected by industry-standard encryption and verified payment gateways to ensure confidentiality and fund security.

Disclaimer

All products listed are intended for laboratory research use only and not for human or veterinary use. They are not drugs, medical devices, or diagnostics and should not be administered to humans or animals. Researchers must handle all materials in accordance with institutional biosafety and chemical safety guidelines. The information provided is for scientific reference only and does not imply therapeutic efficacy, safety, or regulatory approval.